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PCR Assay for Diagnosis and Species Identification of
Microsporidia in Clinical Samples
Joveeta Joseph,1 Savitri Sharma,1 Somasheila I. Murthy,2 Pravin V. Krishna,2
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PURPOSE. To evaluate 16S rRNA–based polymerase chain reac-
tions for the detection and species identification of the micro-
sporidia that cause keratitis.
METHODS. Of the 5892 cases of microbial keratitis seen be-
tween September 2002 and December 2005, 31 (0.5%) micro-
scopically diagnosed cases of microsporidial keratitis were
included in the test group; 103 patients with nonmicrospo-
ridial keratitis constituted the control group. A 16S rRNA-based
pan-microsporidian PCR was chosen for the detection of mi-
crosporidian DNA. Species level identification was made using
species-specific primer sets of Encephalitozoon spp (E. cunic-
uli, E. hellem, and E. intestinalis). Sequencing and BLAST
analysis of amplicons obtained with pan-microsporidian prim-
ers were performed for validation.
RESULTS. The corneal scrapings from 26 of 31 cases in the test
group and 2 of 103 cases in the control group showed a 250-
to 280-bp amplicon in PCR by pan-microsporidian primers
(sensitivity of 83% and specificity of 98%). The amplicons of 13
of 26 test group samples were identified by species-specific
PCR: E. cuniculi, n  7 (549 bp); E. hellem; n  3 (549 bp);
E. intestinalis; n  1 (520 bp). The two cases in the control
group were identified to be E. cuniculi. The remaining 15
cases (test group) were confirmed to be Vittaforma corneae
by sequencing and BLAST analysis. All species were confirmed
by sequencing and database homology comparison.
CONCLUSIONS. This study is the first to validate PCR-based assays
for detection of microsporidial DNA in corneal scrapings. Pan
microsporidian PCR can be a useful adjunct with smear exam-
ination in the diagnosis of microsporidial keratitis. (Invest
Ophthalmol Vis Sci. 2006;47:4468–4473) DOI:10.1167/
iovs.06-0376
Microsporidia are obligate intracellular protozoan parasitesthat infect both invertebrates and vertebrates.1 Though
not commonly reported, microsporidial keratitis may in fact
occur more commonly than believed. A case series of five
patients with microsporidial stromal keratitis has been re-
ported recently.2 The same authors also reported a large case
series of microsporidial keratoconjunctivitis.3 Although these
reports have increased awareness about this emerging ocular
pathogen, a concerted approach is needed to define the true
epidemiologic extent of microsporidial keratitis. Routine diag-
nosis of microsporidia in clinical laboratories has relied mostly
on special staining and microscopic techniques.1,4 Although it
has been reported that the microscopic evaluation of corneal
scrapings using different stains for the diagnosis of microspo-
ridial keratitis is sensitive,5 these often require expertise and
the inability to differentiate related species in a specimen may
require newer methods to be introduced for the identification
of microsporidia causing keratitis. Accurate identification of
microsporidia is vital for making a quick diagnosis, and species
differentiation of microsporidia may play an important role in
treatment assessment and prognosis as well as in understand-
ing the pathogenesis and epidemiology. Although immunoflu-
orescence staining techniques have been developed for spe-
cies differentiation, they are far from optimal, because of
problems of limited availability of antibodies, nonspecific bind-
ing, and interference from the sample matrix.6,7
The recent development of PCR-based detection methods
has greatly enhanced the sensitivity and specificity for identi-
fying microsporidia,1,4,8,9 and these methods are gradually be-
ing introduced in clinical laboratories. Several single and
nested primer pairs have been reported to amplify gene se-
quences of Encephalitozoon species and Enterocytozoon bie-
neusi.1 Mostly, the small subunit rRNA has been used as the
target gene, but some authors also used the large subunit rRNA
and the intergenic spacer region as a target sequence. How-
ever, these studies have been limited to amplification of DNA
from biopsy, urine, and stool specimens.1 Two main ap-
proaches have been used in the construction of primers that
would amplify all major microsporidian pathogens reported to
cause ocular infections, such as Encephalitozoon spp (E. cu-
niculi, E. hellem, and E. intestinalis), as well as Vittaforma
corneae from ocular specimens.10 In this study, the design of
universal pan-microsporidian primers was chosen for rapid
validation in a clinical setting in an ocular microbiology labo-
ratory and the design of species-specific primers was consid-
ered for the identification of E. hellem, E. cuniculi, and E.
intestinalis DNA from corneal scrapings of patients with mi-
crosporidial keratitis. The results were validated by sequencing
and BLAST analysis.
MATERIALS AND METHODS
Reference Strains of Microsporidia
Standard strains of E. hellem (ATCC 50504), E cuniculi (ATCC 50789),
E. intestinalis (ATCC 50651), and Vittaforma corneae (ATCC 50505)
were obtained from the American Type Culture Collection (Manassas,
VA).
Cultures of bacteria (Staphylococcus epidermidis), fungus (As-
pergillus spp), virus (herpes simplex virus), and Acanthamoeba were
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clinical isolates from corneal scrapings processed in our laboratory.
Human leukocytes were obtained from blood donated by a volunteer.
Maintenance of Reference ATCC Strains
The reference strains were obtained in dry ice. They had been grown
in ATCC CCL-26 (African green monkey) cell line and maintained in
ATCC 30-2003 (Eagle’s minimum essential medium with 2 mM L-
glutamine and Earle’s balance salt solution adjusted to contain 1.2 g/L
sodium bicarbonate, 0.1 mM nonessential amino acids, and 1.0 mM
sodium pyruvate). The cultures were initiated by immediately thawing
the reference strains in a water bath set at 35°C for 2 to 3 minutes and
inoculating the vero cell line (National Facility for Animal Tissue and
Cell Cultures; Pune, Maharashtra, India) that was maintained on Eagle’s
minimum essential medium (EMEM) fortified with 2 mM glutamine and
10% fetal bovine serum (FBS). The medium also contained 50 g of
gentamicin, 1000 units of penicillin, and 5 g of amphotericin B per
milliliter to prevent bacterial and fungal overgrowth. The culture
medium from each flask was removed daily for the first week and twice
weekly thereafter and replaced with fresh medium containing the
antibiotics. The cultures were incubated at 37°C. After 4 to 6 weeks,
when infection of a maximum number of host cells (70%) was
achieved, the cells along with the spores were scraped with a cell
scraper, and transferred, and processed for DNA extraction.
Clinical Examination of Patients
The medical records and laboratory records of all patients with micro-
biologically proven microsporidial keratitis seen at the L. V. Prasad Eye
Institute, Hyderabad, India, between September 2002 and December
2005 were retrospectively reviewed. In addition, 103 patients with
suspected microbial keratitis who had a corneal scraping smear nega-
tive for microsporidia were included as the control group. After rele-
vant history was recorded and careful slit lamp examination per-
formed, the patients were subjected to microbiologic analysis.
Microbiologic Investigation of Clinical Samples
The microbiologic work-up included collection of corneal scrapings by
an ophthalmologist using a sterile blade number 15 on a Bard Parker
handle, under a slit lamp biomicroscope. In all cases, the cornea was
topically anesthetized (1% proparacaine hydrochloride; Sunways, India
Pvt. Ltd., Mumbai, India) before scraping. Multiple scrapings were
taken from the lesions and smeared on presterilized slides for staining.
These procedures have been described in detail in an earlier publica-
tion.11 In general, smears of corneal scrapings were stained with (1)
potassium hydroxidecalcofluor white (KOHCFW; Sigma-Aldrich,
St. Louis, MO), (2) Gram’s stain (HiMedia, Mumbai, India), (3) Giemsa
stain (Diff Quick, an equivalent of the Wright/Giemsa stain; Bacto
Laboratories Pty. Ltd., Liverpool, NSW, Australia) and (4) modified
Ziehl Neelsen stain (1% H2SO4; HiMedia). Material was also inoculated
onto blood agar, Sabouraud dextrose agar, and brain–heart infusion
broth (HiMedia). Scrapings were also collected in 0.5 mL of phosphate-
buffered saline (pH 7.2) and stored at 20°C until tested by PCR.
Additional scrapings were taken from cases with suspected viral
keratitis and smeared on a glass slide for immunofluorescence assay
(IFA), which was performed as described earlier.12 The primer details
and PCR procedure were as per our earlier publication.13
DNA Extraction
The harvested vero cells infected with reference strains of microspo-
ridia, as well as the clinical samples were centrifuged at 1500g for 3
minutes. The pellet was washed twice using 5 mL of PBS buffer and
resuspended in 0.5 mL of lysis buffer (8 M urea, 2% SDS, 0.15 M NaCl,
0.001 M EDTA, 0.1 M Tris-HCl; Unset; Sigma-Aldrich) for DNA isolation.
The aqueous lysate was extracted twice with 0.5 mL of phenol-chlo-
roform-isoamyl alcohol (25:24:1). The DNA was finally precipitated
using 0.1 mL volume of 3 M NaCl and 2 volumes of ethanol and
resuspended in 50 L of double-autoclaved water (Milli Q; Millipore,
Bedford, MA).
The DNA was extracted from Mycobacterium tuberculosis, As-
pergillus species, herpes simplex virus, Acanthamoeba, and human
leukocytes, according to procedures described elsewhere.14–17
Standardization of Polymerase Chain Reaction
The pan-microsporidian primers were designed according to se-
quences published by Muller et al.,10 to amplify a conserved region of
the small-subunit (SSU)-rRNA of V. corneae, E. cuniculi, E. hellem, and
E. intestinalis. These primers generate amplicons of 268 bp for E.
cuniculi, 270 bp for E. intestinalis, 279 bp for E. hellem, and 250 bp
for V. corneae. For species identification, the primers used in our study
were based on the published sequences of E. hellem, E. cuniculi, and
E. intestinalis SSU-rRNA.18–20
The primer pairs were tested initially for amplification of the
reference strains obtained from culture, before using them on clinical
samples. The PCR conditions and the amplicon size for all the PCR
assays are outlined in Table 1.
Each set of reactions included a negative reagent control and 1 L
of extracted DNA positive control from the reference strains. All PCR
reactions were performed in a laminar flow hood after 30 minutes of
UV irradiation, to decontaminate surfaces and all supplies within the
hood. Presterilized PCR tubes and double autoclaved water were used
to reduce the possibility of contamination. The products of amplifica-
tion were electrophoretically resolved on a 1.5% agarose gel and
visualized for analysis after being stained with ethidium bromide.
TABLE 1. Details of the Primer Sequences and PCR Conditions and Amplicon Size for 16S rRNA Gene-Based PCR Assays Used in the Study
Subject Organism Primer Sequence PCR Conditions
Amplicon
Size (bp)
1 Pan-microsporidian F: 5-CACCAGGTTGATTCTGCCTGAC-3 Denaturation 94°C, 1 min 250–280
R: 5-CCTCTCCGGAACCAAACCCTG-3 Annealing 55°C, 2 min 35 cycles
Elongation 72°C, 3 min
2 E. cuniculi F 5-ATGAGAAGTGATGTGTGTGCG-3 Denaturation 94°C, 30 sec 549
R 5-TGCCATGCACTCACAGGCATC-3 Annealing 55°C, 1 min 35 cycles
Elongation 72°C, 2 min
Extension 72°C, 5 min
3 E. hellem F: 5-TGAGAAGTAAGATGTTTAGCA-3 Initial denaturation 94°C, 5 min 547
R 5-GTAAAAACACTCTCACACTCA-3 Denaturation 94°C, 1 min
Annealing 55°C, 1 min 39 cycles
Extension 72°C, 1 min
4 E. intestinalis F: 5-TTTCGAGTGTAAAGGAGTCGA-3 Denaturation 94°C, 1 min 520
R: 5-CCGTCCTCGTTCTCCTGC-3 Annealing 55°C, 1 min 35 cycles
Extension 72°C, 90 sec
F, forward; R, reverse.
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Analytical Specificity of Primers
All the primer pairs were tested against clinical isolates of Mycobacte-
rium tuberculosis, Aspergillus species, herpes simplex virus, Acan-
thamoeba and human leukocytes DNA along with a negative reagent
control and positive control of DNA obtained from reference strains.
Analytical Sensitivity of PCR
The DNA isolated from the standard ATCC strains was serially diluted
(100 ng/mL to 100 fg/mL) and amplified using specific primers along
with a negative reagent control and neat undiluted DNA of all strains as
positive controls.
PCR-Based Diagnosis of Clinical Samples
After standardization of the PCRs the ability of the primers to detect
microsporidian DNA in clinical specimens from test and control groups
was tested. PCR was performed on the DNA extracted from corneal
scrapings (3 L template) using the pan-microsporidian primers. All
samples that tested positive using pan-microsporidian primers were
tested with species-specific primer pairs for species identification of
Encephalitozoon spp. The DNA extract of respective reference strains
was used a positive control against each primer and a suitable negative
reagent control was used.
Test for PCR Inhibitors in Clinical Samples
To test the presence of PCR inhibitors, the samples that tested negative
with the pan-microsporidian primers were spiked with 1 pg DNA of E.
hellem and subjected to PCR.
Sequencing
The PCR products of all samples that tested positive using pan-micro-
sporidian and species-specific primers were purified (QIA-quick PCR
purification kit; Qiagen, Hilden, Germany) and were resuspended in
sterile water. The corresponding forward PCR primer was then used
for dye termination PCR sequencing, which was performed at the
GENEI Sequencing Facility, Bangalore, India.
16S rRNA Sequence Analysis
Database homology searching was performed with BLAST 2.0 on the
National Center for Biotechnology Information’s Web Site (http://
www.ncbi.nlm.nih.gov).
RESULTS
Of the 5892 cases of microbial keratitis seen during the study
period, 2960 were culture-positive for bacteria, fungus, Acan-
thamoeba, or mixed infection. In 31 patients (0.5%) micros-
poridial keratitis/keratoconjunctivitis was diagnosed, based on
demonstration of typical spores of microsporidia in any one or
more of the smear examination methods of corneal scrapings.
The demographic details and predisposing factors are shown in
Table 2. Twenty-one of 31 patients, were male and 10 were
female. The mean age of the patients was 35.87  16.47 years
(range, 2–73). Of the 31 patients with microsporidial keratitis,
the clinical diagnosis in 27 was superficial keratoconjunctivitis,
and in 4 it was stromal keratitis. In 11 patients, a predisposing
factor related to trauma was identified. Three patients gave a
history of bathing in unclean river water, and three had a
history of use of topical corticosteroids. One patient reported
applying honey to his eyes. In the remaining 12, the predis-
posing factor could not be ascertained. None of the patients
wore contact lenses.
Also shown in Table 2 are the microbiologic tests and PCR
results of all 31 patients in the test group. Microsporidial
spores were detected by KOHCFW in 29 of 31 samples
(93.5%; 95% CI 84.9–100), by Gram’s stain in 28 of 31 samples
(90.3%; 95% CI 79.9–100), by Giemsa stain in 20 of 31 samples
(64.52%; 95% CI 47.67–81.37), and by modified Ziehl Neelsen
stain in 27 of 31 samples (87%; 95% CI 75.29–98.89). Direct
examination of the corneal scrapings did not reveal any other
bacteria or fungi in any of the cases (Table 2). One of 11
patients tested by viral investigations was positive for herpes
simplex virus (HSV) antigen by IFA and HSV DNA by PCR.
Of the 103 patients included in the control group, 75 were
male and 28 female. The mean age of the patients was 41.5 
19.1 years (range, 3–85). Although culture from 40 cases grew
bacteria, 13 grew fungus and 9 showed the presence of Acan-
thamoeba (Table 2). Culture was not collected in eight cases
that were submitted for viral investigations. The corneal scrap-
ings were sterile in culture in 33 cases.
Analytical Specificity and Sensitivity of the
Primers Used for PCR
With pan-microsporidian primers, an expected diagnostic am-
plicon of approximately 250 to 280 bp was amplified from
DNA of all reference strains. All three primer pairs of Enceph-
alitozoon spp amplified, an expected, amplicon of approxi-
mately 520 to 549 bp for each reference strain. No amplicons
were obtained with Mycobacterium tuberculosis, Aspergillus
spp, Acanthamoeba, herpes simplex virus, and human leuko-
cyte DNA. DNA up to 10 pg for all the strains using pan-
microsporidia primers could be detected. Using species-spe-
cific primers, E. hellem and E. cuniculi of DNA up to 10 pg
was detected, and for E. intestinalis DNA up to 1 pg was
detected.
Validation of PCR on Clinical Samples
Using pan-microsporidian primers, the corneal scrapings from
26 of the 31 cases showed a 250- to 280-bp amplicon (Fig. 1)
in PCR. The results of PCR in correlation with microscopy in all
the cases are shown in Table 2 Of the 103 samples in the
control group 101 tested negative, and two samples showed an
amplification of 250 bp with pan-microsporidian primers.
Using microscopic detection of microsporidia in corneal
scrapings as the gold standard, we had 26 true positives, 2 false
positives, 5 false negatives, and 101 true negatives. Thus, our
PCR using pan-microsporidian primers was estimated to have a
sensitivity of at least 83% and a specificity of 98%.
Of the 26 samples in the study group that were PCR positive
with the pan-microsporidian primers, 7 samples showed an
amplification of 549 bp (Fig. 2a) with primers specific for E.
cuniculi, 3 showed an amplification of 547 bp (Fig. 2b) with
primers specific for E. hellem, and 1 showed an amplification
of 520 bp with primers specific for E. intestinalis (Fig. 2c).
Fifteen samples positive by pan-microsporidian primers did not
show any amplification with all three primers. The two sam-
ples in the control group that were positive using pan-micros-
poridian primers, showed an amplification of 549 bp with
primers specific for E. cuniculi.
Test for PCR Inhibitors in Clinical Samples
An expected amplification corresponding to 270 bp specific
for E. hellem was obtained with all samples in both the test and
control groups after spiking, which ruled out the presence of
PCR inhibitors in the clinical samples.
Sequencing and Database Homology Comparison
Using DNA sequence analysis for amplicons with generic (pan-
microsporidian) primers for unknown microsporidia species,
the sequence of 15 samples exhibited 96% to 99% homology
with the V. corneae 16S-rRNA sequences available in GenBank
(http://www.ncbi.nlm.nih.gov/Genbank; provided in the pub-
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lic domain by the National Center for Biotechnology Informa-
tion, Bethesda, MD) and hence a positive identification of this
species was made for these 15 samples. The species identifi-
cation made by PCR using the species-specific primers for the
remaining 11 isolates in the study group as well as the two
isolates in the control group were also confirmed after se-
quencing the amplicons obtained by PCRs with both generic
and species-specific primers. The sequence homology was 96%
to 99% after BLAST analysis in all cases. The details are given in
Table 2.
DISCUSSION
Routinely used microbiologic staining techniques have been
shown to have a high sensitivity and specificity in the detection
of microsporidia in ocular samples.5 However, a practical and
simple confirmatory test to support direct smear examination
findings is not available. Apart from being subjective, detection
of microsporidial spores in smears requires expertise and train-
ing In addition, the species of microsporidia cannot be deter-
mined by these staining techniques. A technique that is rapid,
sensitive, scaleable, and capable of being used for the identifi-
cation of human pathogenic microsporidia to the species level,
in both clinical and environmental sample matrices, has been
lacking to date. Culture of microsporidia requires access to
tissue culture facilities which, apart from being expensive, are
unable to identify species. Consequently, a strong effort is
being directed toward development and application of molec-
ular biology methods, particularly PCR, to increase the levels of
reliability, for detection and species identification of microspo-
ridia. This test can be easily added to the armamentarium of
diagnostic methods in a microbiology laboratory.
To enhance our diagnostic capability, we decided to in-
clude PCR for detection of four species of microsporidia in
corneal scrapings, in addition to smear examination. Confirma-
tion of smear results using PCR with pan-microsporidian prim-
ers can increase confidence in making the diagnosis of micros-
poridial keratitis. Although PCR-based assays for the detection
of microsporidia in stools, urine, and sputum have been de-
scribed,1,8–10 none has been tested on corneal scrapings. To
validate the PCR method on clinical samples, in this study, 31
samples from the test group and 103 from the control subjects
were examined using pan-microsporidial PCR. The results
showed that 26 of the test samples were PCR positive. Five
smear-positive samples were not positive by these primers
probably due to lack of DNA in the sample, since invariably the
last scraping was used for PCR. Another possibility could be
the presence of other species of microsporidia that are not
detectable by the pan-microsporidia primers. Possibility of PCR
inhibitors was ruled out in these samples.
Two samples in the control group were positive with pan-
microsporidian primers. These were identified as E. cuniculi
with species-specific primers and confirmed by sequencing
and database homology comparison. A review of clinical
records of these two patients showed that they had had mi-
crosporidial keratoconjunctivitis clinically diagnosed and that
they had a few, minute, coarse, punctate, superficial epithelial
lesions on the cornea, with associated conjunctivitis. These
cases were probably missed on direct examination of corneal
scrapings. One patient was seen in the emergency clinic whose
scraping was collected after working hours of the laboratory,
and the smears were examined on the following day. This
delay may account for quenching of the fluorescence from the
calcofluor white-stained smear and may have caused an error in
interpretation. The cause of missing the diagnosis in the sec-
ond case, however, could not be established. Because the
corneal lesions were very minimal, it is possible that the occa-
sional spores in the smears missed detection. This study has
shown PCR using pan-microsporidian primers to have a sensi-
tivity of at least 83% and specificity of 98%. Considering the
low prevalence of the disease, a very large sample size of
negative control subjects would be necessary to be tested to
determine predictive values of the PCR assays. Owing to this
limitation in this study, the positive predictive value was 21.9%
after adjustment with Bayes Theorem. The negative predictive
value of the assay was 95.3%, however. The sensitivity may
improve by further optimizing PCR reaction conditions; nev-
ertheless, the results of this study indicate that pan-microspo-
ridia PCR can be used in routine diagnosis for a quick confir-
mation of the clinical diagnosis. This PCR can also be used for
epidemiologic studies as a means to define the source and
spread of human microsporidian infections. The limitation of
this PCR is that the species-representative amplicons are too
close in size to be distinguished from each other.
Species-specific identification of microsporidia in clinical
specimens is becoming increasingly important because of var-
ious levels of responses to some drugs.1 Although albendazole
and fumagillin have been reported to be useful against many
species of Encephalitozoon, no drug has been shown to be
effective against E. bieneusi.1 Though most species of micros-
poridia respond favorably to fumagillin in the United States,1
these may be only anecdotal observations and blinded, place-
bo-controlled, comparative trials are lacking to date. Therefore,
these PCR assays may also find utility as a means of monitoring
the effectiveness of antimicrosporidial therapy.
FIGURE 1. Image of a gel, showing results of PCR with pan-microspo-
ridian primers used on 13 corneal scrapings. Lanes 3, 7, 9, 10, and 12:
negative, showing no amplicon; lanes 1, 2, 4–6, 8, 11, and 13: show
positivity for microsporidian DNA. NC, negative control; PC, positive
control (V. corneae), lane M: 100-bp marker.
FIGURE 2. Gel photograph of ocular
samples showing amplification with
primers specific for (a) E. cuniculi in
lanes 1 to 7 (patients 14, 16, 17, 19,
20, 24, 25); (b) E. hellem in lanes 1,
4 (patients 8, 10, 31); (c) E. intesti-
nalis in lane S (patient 25). NC, neg-
ative control; PC, positive control.
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The ability of PCR sequencing and database searching to
distinguish between very closely related species has already
been shown1 and allows human and nonhuman microsporidia
to be distinguished. This study considered a homology of 96%
or above to be definitive. Amplicons showing less than 100%
homology to the database sequences in our cases were prob-
ably due to the computer sequencing software’s inability to
identify bases during sequencing, especially when the sequenc-
ing software incorporated an “N” in place of an actual base due
to a weak or covered signal from the actual base. Taking this
and the fidelity of Taq polymerase into account, we felt
thought that at least 96% homology was necessary for definitive
species determination of microsporidia. Examination of se-
quences deposited in GenBank for the gene encoding the SSU
rRNA of E. hellem, E. cuniculi, E. intestinalis, and V. corneae
reveals considerable disagreement about the degree of se-
quence conservation in the 5 region (base pairs 1–300) of this
gene. Because DNA from all four parasites was efficiently am-
plified in the assay using the pan-microsporidian primers, it is
concluded that this region covered by the primer is conserved
in these organisms and therefore a single PCR using these
primers can be a useful adjunct to smear examination of cor-
neal scrapings by routine staining methods. In epidemiologic
studies that require species identification, one may use se-
quencing after pan-microsporidian PCR or resort to species-
specific PCR.
To the best of our knowledge, this is the first study in which
PCR was used for detection and identification of species of
microsporidia from ocular specimens. The short time and rel-
atively lower cost and expertise required for PCR testing is a
distinct advantage over electron microscopy. We believe that
our work will increase the awareness of this rare disease and
open avenues for further research.
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